Connect with us

Technology

Study Finds Telemedicine Improves Care for Children with Eye Cancer

Published

13 hours ago

on

The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how telemedicine improves outcomes for children with retinoblastoma through e-learning and virtual mentorship

NEW YORK, Dec. 20, 2024 /PRNewswire/ — Orbis International announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships through Cybersight, Orbis’s free telemedicine and e-learning platform, not only improves lives, but can save them by successfully transferring skills to eye care professionals in low- and middle-income countries.

Each year, about 9,000 children worldwide are diagnosed with retinoblastoma, but only 40% survive beyond three years. This is because 92 percent of these children live in low-and-middle-income countries, where retinoblastoma patients face late diagnosis and limited access to eye care. This groundbreaking research was supported by Heidelberg Engineering, a global leader in advanced imaging solutions. Their funding has been crucial in delivering e-learning webinars, alongside advancing research through Orbis’s Cybersight platform.

“Retinoblastoma can be treated if caught early, but too often, it’s not diagnosed until it’s too late,” said Dr. Hunter Cherwek, Vice President of Clinical Services and Technologies at Orbis International. “Many low- and middle-incomes countries don’t have enough resources to provide proper care, but technology offers a solution. This study shows that telemedicine can improve health outcomes for children, especially in remote areas where pediatric eye doctors are scarce.”

Cybersight has long been used to diagnose and treat diabetic retinopathy, retinopathy of prematurity, and other eye diseases, but this is the first research on its impact on retinoblastoma. The groundbreaking study explored whether Cybersight Consult – a component of the Cybersight platform that connects mentee doctors with expert mentors for advice on complex clinical cases – could improve care and treatment for retinoblastoma. Researchers also examined how virtual mentoring helps eye care professionals build expertise in retinoblastoma over time.

Researchers conducted a retrospective review of 653 Cybersight retinoblastoma consultations undertaken by 38 different mentees from 2004 to 2023. They found significant improvements in knowledge-sharing over this 20-year period, especially in three areas: understanding and recording patient symptoms, classifying the disease’s type and how advanced it is, and the results of treatment for both the patient and their eye health. Cybersight’s virtual mentorship approach helped mentees gain critical skills to treat retinoblastoma, especially in regions with few eye care resources.

Cybersight provides training, mentoring, and online courses to eye care professionals around the world. The platform has helped train eye care professionals in nearly every country and territory and counts around 15% of the world’s ophthalmologists as registered users.

The study reveals the potential of using communication and digital technologies to help children around the world see – and survive.

About Orbis International
Orbis is an international nonprofit delivering sight-saving programs in over 200 countries and territories worldwide so that individuals, families, and communities can thrive. Currently, around 1 billion people across the globe live with completely avoidable blindness and vision loss. For over four decades, Orbis has been tackling this challenge by building strong and sustainable eye care systems that leave a lasting legacy of vision. Orbis runs dedicated in-country programs in Africa, Asia, the Caribbean, and Latin America; develops and implements innovative training and technology, including an award-winning telemedicine and e-learning platform, Cybersight; and operates the world’s first and only Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. For the past 11 consecutive years, Orbis has achieved Charity Navigator‘s coveted four-star rating for demonstrating strong financial health and commitment to accountability and transparency, placing Orbis in the top 3% of U.S. charities. For the past three years, Orbis has earned GuideStar‘s platinum Seal of Transparency. Since 2022, Orbis has earned “accredited charity” status from the Better Business Bureau by meeting all 20 of their standards for charity accountability. To learn more, please visit orbis.org.

MEDIA CONTACT

Jenna Montgomery
Manager, Global Communications and Marketing
jenna.montgomery@orbis.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/study-finds-telemedicine-improves-care-for-children-with-eye-cancer-302337562.html

SOURCE Orbis International

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Samsung Press Conference at CES 2025 ‘AI for All: Everyday, Everywhere’

Published

11 minutes ago

on

December 21, 2024

By

KUALA LUMPUR, Malaysia, Dec. 21, 2024 /PRNewswire/ — Samsung Electronics will hold a press conference on January 6, a day before exhibitions open for CES 2025 in Las Vegas, NV.

The event is scheduled to begin at 6:00 a.m. MYT (Malaysia Time) (5:00 p.m. EST) at the Mandalay Bay Ballroom, South Convention Center, Mandalay Bay Hotel. Jong-Hee (JH) Han, Vice Chairman, CEO and Head of Samsung’s DX (Device eXperience) Division, will open the press conference, introducing the theme of ‘AI for All: Everyday, Everywhere.’

The press conference will be streamed live on Samsung Newsroom. Until then, stay tuned to Samsung Newsroom for more updates on the company’s plans for CES 2025.

About Samsung Electronics Co., Ltd.

Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, home appliances, network systems, and memory, system LSI, foundry and LED solutions, and delivering a seamless connected experience through its SmartThings ecosystem and open collaboration with partners. For the latest news, please visit the Samsung Newsroom at news.samsung.com.

“SAMSUNG MALAYSIA ELECTRONICS (SME) SDN BHD [Company No. 200301026766(629186-D)]”.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/samsung-press-conference-at-ces-2025-ai-for-all-everyday-everywhere-302337844.html

SOURCE Samsung Electronics

Continue Reading

Technology

ZeroThreat, a Rising AppSec Innovator, to Showcase AI-Powered Security at Gujarat’s Largest Tech Expo

Published

1 hour ago

on

December 21, 2024

By

Enabling complete web and API security with AI-powered real-time vulnerability scanning, actionable insights, automated pentesting, remediation, and continuous security testing for modern applications.

AHMEDABAD, India, Dec. 20, 2024 /PRNewswire-PRWeb/ — ZeroThreat, an AI-powered Web Application and API security startup, is all set to make its mark at Gujarat’s largest Tech Expo, happening in Ahmedabad on December 20-21, 2024 Booth #G3. As a standout name in AppSec innovation, ZeroThreat is redefining how software teams build secure applications and APIs.

With its cutting-edge AI-driven platform, ZeroThreat offers unparalleled ease of use, requiring zero configurations and delivering point-and-click simplicity. Teams can detect vulnerabilities 5x faster with real-time scanning, automate pentesting, and produce compliance-ready products—ensuring proactive protection against modern threats.

In today’s fast-paced world, where software and B2B SaaS companies face relentless pressure to deliver rapid updates, ZeroThreat emerges as the ultimate solution to tackle critical security challenges. Tech Expo visitors will have the exclusive opportunity to witness its capabilities live, from real-time vulnerability detection to seamless API discovery at booth #G3.

Tech Expo Gujarat 2024, scheduled for December 20-21, 2024, at Ahmedabad, Gujarat, will bring together over 5000+ attendees, 20+ speakers, 125+ exhibitors, and 50+ sponsors. This one of the largest technology events serves as a premier platform to explore cutting-edge technological advancements and foster collaboration among industry leaders, decision-makers, and innovators.

ZeroThreat – Web Application and API Scanning Platform Highlights

Sensitive Data Exposure & Data Leak DetectionDetect Session Hijacking, Broken Access, XSS & SQL InjectionsAI-Guided Detection & RemediationRapid Port and Configuration ScanningOptimized for Modern Apps & SPA FrameworksFully Automated Authorization Checks

Designed for modern AppSec, ZeroThreat shortens vulnerability detection and resolution from days to hours, empowering businesses to launch secure products on time. As a standout DAST platform, it tackles complex configurations and eliminates the need for expert pentester, solving key challenges for software companies.

Key Benefits for Software Teams and Companies

ZeroThreat comes with several benefits for software companies and engineers that enhance security, productivity, and cost efficiency.

Point-and-Click Scan: Flawlessly scan your web apps without complex configurations and technical expertise required.Faster Vulnerability Detection: Detect 40,000+ vulnerabilities 5x faster than traditional methods, helping software teams to address issues quickly.Near-Zero False Positives: Minimize false positives to reduce alert fatigue with 98.9% accuracy.AI-Powered Remediation Reports: Get personalized code examples and actionable insights to fix vulnerabilities faster.CI/CD Integration: Integrate security seamlessly into your development process with CI/CD integration, ensuring minimal workflow disruption.Automated Compliance Check: Ensure adherence to security standards and regulations like GDPR, SOC2, PCI-DSS, OWASP, CWE/SANS and HIPAA, streamlining the compliance process.Location-based Data Storage and Scan: Choose a preferred global scanning location and store data in compliance with regional regulations.

A Commitment to APPSec Innovation

Empowering software teams with robust AppSec solutions is at the core of our mission,” said Dharmesh Acharya, Co-Founder of ZeroThreat.” At Gujarat’s largest tech expo, we’re excited to showcase how ZeroThreat helps businesses build secure applications easily, integrating security into workflows without compromising speed or efficiency.

About ZeroThreat

ZeroThreat is an AI-driven vulnerability scanning and pentesting platform providing comprehensive security solutions for web applications and APIs. It scans all types of web apps, including modern Single-Page Applications, JavaScript-heavy ones and APIs (Private, Public) to minimize external attacks and false positives by 90% manual pentesting. ZeroThreat empowers software teams and companies with robust security capabilities, ensuring the integrity and confidentiality of their applications and data.

Media Contact

Dharmesh Acharya, ZeroThreat, 91 9081579038, marketing@zerothreat.ai, https://zerothreat.ai/

View original content to download multimedia:https://www.prweb.com/releases/zerothreat-a-rising-appsec-innovator-to-showcase-ai-powered-security-at-gujarats-largest-tech-expo-302337016.html

SOURCE ZeroThreat

Continue Reading

Technology

EXRO PROVIDES UPDATE ON SEMI-ANNUAL INTEREST PAYMENTS ON OUTSTANDING CONVERTIBLE DEBENTURES

Published

5 hours ago

on

December 21, 2024

By

CALGARY, AB, Dec. 20, 2024 /PRNewswire/ – Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that provides new-generation power control electronics that expand the capabilities of electric motors and batteries, is pleased to provide an update on the settlement of interest payments through the issuance of common shares.

Pursuant to the terms of the C$15,000,000 secured convertible debentures of the Company issued on December 30, 2022 (the “Debentures”), bearing interest at 12% per annum, payable semi-annually in arrears beginning on June 30, 2023 (the “Due Date”). As of December 20, 2024 the Company has 14,950 debenture units outstanding, and an aggregate amount of interest owing on the Debentures payable of C$897,000 (the “Interest”). The Company has elected to issue 6,407,141 common shares in the capital of the Company (“Common Shares”) at a deemed price of $0.14 to the debenture holders as payment for the interest. Pursuant to the Debentures, the deemed issue price per Common Share is calculated based on the volume weighted average trading price of the Common Shares for the five trading days immediately prior to December 20, 2024.

The issuance of the Common Shares as payment for interest owing on the Debentures is subject to the terms and conditions of the Debentures as well as the receipt of all requisite approvals, including, without limitation, the approval of the Toronto Stock Exchange.

About Exro Technologies Inc.

Exro Technologies Inc., now expanded through the strategic acquisition of SEA Electric, is a leading clean technology company that has developed new generation power control electronics. Its innovative suite of solutions, including Coil Driver™, Cell Driver™, and SEA-Drive®, expand the capabilities of electric motors and batteries and offer OEMs a comprehensive e-propulsion solution with unmatched performance and efficiency. Exro is reshaping global energy consumption, accelerating adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results.

For more information, please visit www.exro.com.

To view our Investor Presentation, visit us at www.exro.com/investors.

Follow us on social media @Exrotech.

View original content to download multimedia:https://www.prnewswire.com/news-releases/exro-provides-update-on-semi-annual-interest-payments-on-outstanding-convertible-debentures-302337807.html

SOURCE Exro Technologies Inc.

Continue Reading

Trending